AI assistant
AMICUS THERAPEUTICS, INC. — Director's Dealing 2015
Jun 24, 2015
31523_dirs_2015-06-24_1d1545dd-bd68-40f3-adfb-da0761b2793f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AMICUS THERAPEUTICS INC (FOLD)
CIK: 0001178879
Period of Report: 2015-06-23
Reporting Person: HAYDEN DONALD J JR (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-06-23 | Common stock | M | 55000 | $14.0071 | Acquired | 55000 | Direct |
| 2015-06-23 | Common stock | S | 55000 | $14.0071 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-23 | Stock Options (right to buy) | $2.81 | M | 10000 | Disposed | 2020-06-15 | Common Stock (10000) | Direct |
| 2015-06-23 | Stock Options (right to buy) | $4.79 | M | 15000 | Disposed | 2022-06-13 | Common Stock (15000) | Direct |
| 2015-06-23 | Stock Options (right to buy) | $3.32 | M | 15000 | Disposed | 2023-06-13 | Common Stock (15000) | Direct |
| 2015-06-23 | Stock Options (right to buy) | $2.80 | M | 15000 | Disposed | 2024-06-12 | Common Stock (15000) | Direct |
Footnotes
F1: The exercise of stock options and subsequent sale of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 22, 2015.
F2: This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.84 to $14.17. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.84 to $14.17. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.